Product image of Oxycodone Abboxia (Oxycodone Hydrochloride) supplied by GNH India

Oxycodone Abboxia

Active Ingredient:
Oxycodone Hydrochloride
Origin:
EU

Oxycodone Abboxia (Oxycodone Hydrochloride)

Oxycodone, the active ingredient in Oxycodone Abboxia, is an opioid analgesic presented as an injectable solution for intramuscular, intravenous, and subcutaneous use. It is employed to manage moderate to severe pain in adult patients when other analgesics are insufficient, and it complies with EU regulatory standards as a Schedule II controlled substance.

GNH India supplies Oxycodone Abboxia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and adherence to stringent quality‑assurance protocols across multiple regions.

Manufacturer / TM Owner

Abboxia Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Oxycodone is an opioid analgesic used in the management of pain across several clinical contexts.

  • Acute postoperative pain: provides rapid analgesia to facilitate recovery after surgery.
  • Cancer‑related pain: alleviates moderate to severe pain associated with malignant disease.
  • Chronic severe pain: offers sustained relief for patients with persistent, high‑intensity pain unresponsive to non‑opioid therapies.

How It Works

  • Oxycodone exerts its effect by acting as a full agonist at the μ‑opioid receptors in the central nervous system. Binding to these G‑protein‑coupled receptors inhibits adenylate cyclase activity, reduces neuronal excitability, and diminishes the transmission of nociceptive signals. These actions also modulate dopamine pathways, contributing to the drug’s rewarding properties and potential for dependence.

Side Effects

Oxycodone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: feeling of sickness often accompanied by an urge to vomit.
  • Constipation: reduced bowel movements and hard stools.
  • Drowsiness: increased sleepiness or fatigue.
  • Dry mouth: reduced salivation leading to a parched feeling.

Serious or Rare Side Effects

  • Respiratory depression: slowed or shallow breathing that can be life‑threatening.
  • Severe hypotension: marked drop in blood pressure causing faintness.
  • Anaphylaxis: acute allergic reaction with hives, swelling, and airway compromise.

Precautions & Warnings

When using Oxycodone, careful assessment and monitoring are essential to minimize risks.

  • Assess pain severity: confirm that opioid therapy is appropriate for the level of pain.
  • Evaluate respiratory function: monitor breathing rate and oxygen saturation, especially after dose initiation.
  • Review patient history: identify prior opioid use, substance‑use disorder, or hypersensitivity.
  • Use caution in the elderly: start with lower doses and observe for increased sedation.
  • Avoid concurrent CNS depressants: limit use of benzodiazepines, alcohol, or other sedatives.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Oxycodone can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Benzodiazepines or other CNS depressants: may cause profound respiratory depression.
  • MAO inhibitors: can precipitate severe hypertension or serotonin syndrome.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase oxycodone plasma levels and toxicity.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect.
  • Serotonergic agents (e.g., SSRIs, SNRIs): raise risk of serotonin syndrome.
  • Antihistamines or muscle relaxants: can enhance sedative effects.

Frequently Asked Questions

Oxycodone Abboxia is an injectable opioid analgesic indicated for the relief of moderate to severe pain, including acute postoperative pain, cancer‑related pain, and chronic pain that has not responded adequately to non‑opioid therapies.

Oxycodone binds to μ‑opioid receptors in the brain and spinal cord, activating them as a full agonist. This activation inhibits the release of neurotransmitters that transmit pain signals, producing analgesia and a degree of sedation.

The appropriate dose is individualized by the prescribing clinician based on the patient’s pain intensity, prior opioid exposure, age, renal and hepatic function, and any concomitant medications. No fixed regimen is provided in product literature.

Safety data for oxycodone in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant.

Enquiries are submitted through the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Both oxycodone and morphine are μ‑opioid receptor agonists, but oxycodone generally has higher oral bioavailability and may provide a slightly faster onset when given intravenously. Choice between them depends on clinical response, side‑effect profile, and individual patient factors.

Oxycodone Abboxia should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and handle it in accordance with local controlled‑substance regulations.

The product is supplied as an injectable solution and may be given by intramuscular, intravenous, or subcutaneous injection. Administration is performed by qualified healthcare professionals following aseptic technique and appropriate dosing guidelines set by the prescriber.

The most critical risks include respiratory depression, severe hypotension, and anaphylactic reactions. Patients should be monitored for signs of shallow breathing, sudden drop in blood pressure, or allergic symptoms, especially during dose initiation or when combined with other depressants.

Individuals with known hypersensitivity to oxycodone or any component of the formulation, those with severe respiratory insufficiency, acute or severe bronchial asthma, or who are currently taking MAO inhibitors should not receive this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.